Emerging Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Emerging Europe Analysis

Industry Trend Analysis - Czech Republic - Q2 2017 - MAR 2017

Although most innovative drugmakers are present in the Czech market, their manufacturing presence is limited. The vast majority of multinationals import drugs for retail, with a small number of manufacturers, such as GlaxoSmithKline, licensing production to local companies. The Czech Republic has been a challenging market for businesses involved within the production, distribution and retailing...

READ FULL ARTICLE...

Industry Trend Analysis - Mixed Implications Of Regulatory Changes For Drugmakers - FEB 2017

With patient numbers increasing rapidly in the Czech Republic, the availability of medicines has become a more prominent issue. Recent amendments to the country's pharmaceutical law, which are expected to be implemented in 2017, seek to address this by limiting the parallel trade of medicines whilst also reducing the cost of generic and biosimilar medicines. While drugmakers will experience a...

READ FULL ARTICLE...